Jun 10, 2026 07:00AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 11, 2026 07:00AM
Apr 24, 2026 08:30AM
Mar 26, 2026 07:00AM
Mar 19, 2026 04:57PM Gain Therapeutics to Present at the 38th Annual ROTH Conference
Mar 18, 2026 08:15AM
Mar 18, 2026 08:15AM
Mar 12, 2026 07:00AM
Feb 19, 2026 07:00AM
Jan 7, 2026 07:00AM
Jan 6, 2026 07:00AM
Jan 6, 2026 07:00AM Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287
Dec 18, 2025 04:05PM
Dec 18, 2025 07:00AM
Dec 18, 2025 07:00AM
Nov 20, 2025 07:00AM
Nov 12, 2025 07:00AM
Oct 30, 2025 07:00AM
Oct 16, 2025 07:00AM Gain Therapeutics to Attend the 2025 Maxim Growth Summit
Oct 9, 2025 07:00AM
Oct 6, 2025 08:15AM
Oct 6, 2025 08:15AM
Sep 23, 2025 07:40AM
Sep 18, 2025 07:42AM
Sep 18, 2025 07:41AM
Sep 4, 2025 08:00AM Gain Therapeutics gets Australian approval for Phase 1b trial extension
Sep 4, 2025 08:00AM
Aug 12, 2025 07:00AM
Jun 30, 2025 04:05PM
Jun 10, 2025 08:00AM
May 29, 2025 08:45AM
May 14, 2025 07:30AM
May 12, 2025 07:30AM Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
May 1, 2025 07:30AM
Apr 30, 2025 07:45AM
Apr 10, 2025 07:01AM
Apr 10, 2025 07:00AM
Mar 28, 2025 08:30AM
Mar 27, 2025 07:00AM
Feb 6, 2025 08:45AM Gain Therapeutics (GANX) CEO Gene Mack Issues Letter To Shareholders and Provides Operational Update
Feb 6, 2025 08:45AM
Jan 8, 2025 08:01AM
Jan 8, 2025 08:00AM
Nov 25, 2024 06:51AM
Nov 14, 2024 04:05PM
Feb 6, 2024 09:56AM
Feb 6, 2024 08:03AM Gain Therapeutics' (GANX) GT-02287 Completely Restores Motor Function in Mouse Models of Parkinson’s Disease
Feb 6, 2024 08:00AM

323,584 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All